BRPI0811433A2 - compostos do tipo triazolil aminopirimidina - Google Patents

compostos do tipo triazolil aminopirimidina

Info

Publication number
BRPI0811433A2
BRPI0811433A2 BRPI0811433A BRPI0811433A BRPI0811433A2 BR PI0811433 A2 BRPI0811433 A2 BR PI0811433A2 BR PI0811433 A BRPI0811433 A BR PI0811433A BR PI0811433 A BRPI0811433 A BR PI0811433A BR PI0811433 A2 BRPI0811433 A2 BR PI0811433A2
Authority
BR
Brazil
Prior art keywords
compounds
aminopyrimidine
triazolyl
triazolyl aminopyrimidine
Prior art date
Application number
BRPI0811433A
Other languages
English (en)
Portuguese (pt)
Inventor
Delu Jiang
Harold Burns Brooks
Hong Hu
Hong-Yu Li
James Robert Henry
Jason Scott Sawyer
Joyce Z Crich
Melissa Kate Slater
William Thomas Mcmillen
Yan Wang
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BRPI0811433A2 publication Critical patent/BRPI0811433A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0811433A 2007-05-16 2008-05-07 compostos do tipo triazolil aminopirimidina BRPI0811433A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93834707P 2007-05-16 2007-05-16
PCT/US2008/062808 WO2008144223A2 (en) 2007-05-16 2008-05-07 Triazolyl aminopyrimidine compounds

Publications (1)

Publication Number Publication Date
BRPI0811433A2 true BRPI0811433A2 (pt) 2016-03-22

Family

ID=39951591

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0811433A BRPI0811433A2 (pt) 2007-05-16 2008-05-07 compostos do tipo triazolil aminopirimidina

Country Status (15)

Country Link
US (1) US8063035B2 (enExample)
EP (1) EP2155734A2 (enExample)
JP (1) JP5248600B2 (enExample)
KR (1) KR101131261B1 (enExample)
CN (1) CN101679395B (enExample)
AR (1) AR066473A1 (enExample)
AU (1) AU2008254319B2 (enExample)
BR (1) BRPI0811433A2 (enExample)
CA (1) CA2691997A1 (enExample)
CL (1) CL2008001323A1 (enExample)
EA (1) EA016781B1 (enExample)
MX (1) MX2009012228A (enExample)
PE (1) PE20090216A1 (enExample)
TW (1) TW200908981A (enExample)
WO (1) WO2008144223A2 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7964729B2 (en) 2006-08-28 2011-06-21 Massachusetts Institute Of Technology Sox-based kinase sensor
US8101628B2 (en) 2006-12-21 2012-01-24 Eli Lilly And Company Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer
SI2125794T1 (sl) 2006-12-21 2011-02-28 Lilly Co Eli Spojine imidazolidinonil aminopirimidina za zdravljenje raka
US8440835B2 (en) 2007-02-26 2013-05-14 Massachusetts Institute Of Technology Environmentally sensitive fluorophores
EA016781B1 (ru) 2007-05-16 2012-07-30 Эли Лилли Энд Компани Триазолиламинопиримидиновые соединения
WO2008144222A2 (en) * 2007-05-16 2008-11-27 Eli Lilly And Company Triazolyl aminopyrimidine compounds
KR101123178B1 (ko) * 2009-04-09 2012-06-13 (주)에스메디 2-아릴벤조싸이오펜 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 퇴행성 뇌질환의 진단 또는 치료용 약학적 조성물
EP2470652A1 (en) * 2009-08-25 2012-07-04 OncoTherapy Science, Inc. Ercc6l as target genes for cancer therapy and diagnosis
WO2011025546A1 (en) * 2009-08-31 2011-03-03 Massachusetts Institute Of Technology 1, 2, 3-triazole containing protein kinase sensors
UA119247C2 (uk) 2013-09-06 2019-05-27 РОЙВЕНТ САЙЕНСИЗ ҐмбГ Спіроциклічні сполуки як інгібітори триптофангідроксилази
US9611201B2 (en) * 2015-03-05 2017-04-04 Karos Pharmaceuticals, Inc. Processes for preparing (R)-1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanone
JP7090037B2 (ja) * 2016-06-23 2022-06-23 エフ．ホフマン－ラ ロシュ アーゲー 新規な［１，２，３］トリアゾロ［４，５－ｄ］ピリミジン誘導体
US11084829B2 (en) 2018-09-24 2021-08-10 Rapt Therapeutics, Inc. Ubiquitin-specific-processing protease 7 (USP7) modulators and uses thereof
KR20220059951A (ko) * 2019-09-05 2022-05-10 더 유니버시티 오브 멜버른 질화 억제제
CN112341428A (zh) * 2020-11-04 2021-02-09 菏泽鸿特药业有限公司 一种噻吩-2-乙胺的生产方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929726A (en) * 1988-02-09 1990-05-29 Georgia State University Foundation, Inc. Novel diazines and their method of preparation
WO2004063192A1 (en) 2003-01-10 2004-07-29 Pharmacopeia Drug Discovery, Inc. Imidazolyl pyrimidine derivatives useful as il-8 receptor modulators
GB0308466D0 (en) 2003-04-11 2003-05-21 Novartis Ag Organic compounds
JP2007533602A (ja) * 2003-07-31 2007-11-22 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド 置換ベンゾチオフェン化合物及びそれらの使用
AU2005316312B2 (en) * 2004-12-17 2009-10-22 Amgen, Inc. Aminopyrimidine compounds and methods of use
TW200800201A (en) 2005-11-18 2008-01-01 Lilly Co Eli Pyrimidinyl benzothiophene compounds
US8008481B2 (en) 2006-03-31 2011-08-30 Ericsson Anna M Indazole compounds
US8101628B2 (en) 2006-12-21 2012-01-24 Eli Lilly And Company Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer
SI2125794T1 (sl) * 2006-12-21 2011-02-28 Lilly Co Eli Spojine imidazolidinonil aminopirimidina za zdravljenje raka
EA016781B1 (ru) 2007-05-16 2012-07-30 Эли Лилли Энд Компани Триазолиламинопиримидиновые соединения
WO2008144222A2 (en) 2007-05-16 2008-11-27 Eli Lilly And Company Triazolyl aminopyrimidine compounds

Also Published As

Publication number Publication date
EP2155734A2 (en) 2010-02-24
AU2008254319A1 (en) 2008-11-27
US8063035B2 (en) 2011-11-22
WO2008144223A3 (en) 2009-02-05
EA016781B1 (ru) 2012-07-30
JP5248600B2 (ja) 2013-07-31
MX2009012228A (es) 2009-12-01
EA200971068A1 (ru) 2010-04-30
KR101131261B1 (ko) 2012-04-24
CL2008001323A1 (es) 2009-05-29
WO2008144223A2 (en) 2008-11-27
US20100087431A1 (en) 2010-04-08
JP2010527365A (ja) 2010-08-12
TW200908981A (en) 2009-03-01
CN101679395B (zh) 2012-06-13
AR066473A1 (es) 2009-08-19
KR20090130242A (ko) 2009-12-21
PE20090216A1 (es) 2009-02-28
CA2691997A1 (en) 2008-11-27
CN101679395A (zh) 2010-03-24
AU2008254319B2 (en) 2012-04-19

Similar Documents

Publication Publication Date Title
BRPI0813500A2 (pt) Compostos antivirais
BRPI0821086A2 (pt) Compostos inseticidas
ATE502948T1 (de) Substituierte bicyclolactamverbindungen
PT2173888T (pt) Resumo
EP2170350A4 (en) SUBSTITUTED IMIDAZOHETEROCYCLES
ATE542825T1 (de) Substituierte piperidino-dihydrothienopyrimidine
BRPI0821573A2 (pt) benzofuropirimidonas
ATE501136T1 (de) Imidazopyridinone
BRPI0811264A2 (pt) Compostos
ATE514696T1 (de) Diphenyl-dihydro-imidazopyridinone
BRPI0809996A2 (pt) Compostos
BRPI0814424A2 (pt) Compostos heterociclila
DE602008000884D1 (de) Induktionselement
BRPI0811451A2 (pt) Exopolissacarídeo
BRPI0814519A2 (pt) Organopolissiloxano
BRPI0815547A2 (pt) Depsipeptídeos cícliocos
BRPI0812840A2 (pt) 2-imidazolinas
BRPI0812994A2 (pt) Microbiocidas
AT505058A3 (de) Türschliesssystem
BRPI0815181A2 (pt) Compostos
DE112008001216A5 (de) Magnetronplasmaanlage
BRPI0814613A2 (pt) Compostos
LT3825306T (lt) Morfinano junginiai
DE112008002200A5 (de) Sperrsynchronisiervorrichtung
CU20090155A7 (es) Macrolidos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2372 DE 21-06-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.